(Q80477528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Fujii M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Inoguchi T

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Maeda Y

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sasaki S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sawada F

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Saito R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kobayashi K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sumimoto H

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Takayanagi R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

13 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

473-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17568784%20AND%20SRC:MED&resulttype=core&format=json

Free radicals and diabetes

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Role of oxidative stress in development of complications in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Protein glycation and oxidative stress in diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Oxidative damage to DNA in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Hyperglycemic pseudohypoxia and diabetic complications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Mechanisms underlying endothelial dysfunction in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Vascular NAD(P)H oxidases: specific features, expression, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

A novel superoxide-producing NAD(P)H oxidase in kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Identification of renox, an NAD(P)H oxidase in kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

The Nox family of NAD(P)H oxidases: host defense and beyond

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Statins and the acute-phase response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Rho GTPases, statins, and nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Rho GTPases and signaling networks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021

Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002366

7 January 2021